An investigation into the incidence of pain flare in patients receiving palliative radiotherapy for symptomatic bone metastases.
Loading...
Authors
Goldfinch, Rebecca
Issue Date
2017-06-12
Journal
Type
Conference Poster
Poster
Poster
Keywords
Pain
Palliative radiotherapy
Palliative care
Radiotherapy
Bone metastases
External beam radiotherapy (EBRT)
Pain
Toxicity
Deanesly Centre
UK Radiological Congress (UKRC)
UK Radiation Oncology Congress (UKRO)
Palliative radiotherapy
Palliative care
Radiotherapy
Bone metastases
External beam radiotherapy (EBRT)
Pain
Toxicity
Deanesly Centre
UK Radiological Congress (UKRC)
UK Radiation Oncology Congress (UKRO)
Journal Title
Volume
Issue
Begin page
End page
DOI
Abstract
Bone metastases are a frequently occurring complication of many cancers, most commonly Prostate, Breast and Lung. Pain is a common and incapacitating symptom for which External Beam Radiotherapy (EBRT) is a recognised and widely-used intervention2. Pain flare is a reported EBRT toxicity, described in 16–41% of steroid-naïve patients. Pain flare is identified as a transitory increase in pain within the irradiated site6 and is quantified as i) an increase of 2 points on a numerical rating scale with no increase in analgesia, or ii) a 25% increase in analgesia to maintain the previous pain levels. A study was undertaken to determine incidence and duration of pain flare amongst patients within one Oncology Centre, comparing findings with previous
published studies.
Citation
Goldfinch R, White N. "An investigation into the incidence of pain flare in patients receiving palliative radiotherapy for symptomatic bone metastases". [Poster]. Poster presented at: UK Radiological Congress (UKRC) and UK Radiation Oncology Congress (UKRO);12th-14th June 2017 held at Manchester Convesion Centre; Manchester,England.